Facility will be built on a 50-acre site in Vemgal, Karnataka, and is expected to employ 300 people
Work has begun on GSK India's new £100m pharmaceutical factory. When fully operational in 2017, the factory will make more than eight billion tablets and one billion capsules a year for gastroenterology and anti-inflammatory applications. The facility will be built on a 50-acre site in Vemgal, Karnataka, and is expected to employ 300 people.
The new state-of-the-art manufacturing facility is part of GSK's continued commitment to India, ensuring increased access to GSK medicines for Indian people. It will be built in partnership with international and local design and construction companies and will include a warehouse, site infrastructure, employee welfare centre and utilities to support the manufacture and packing of the medicines.
‘GSK has been at the forefront of serving the healthcare needs of India for more than 90 years,' said Annaswamy Vaidheesh, Managing Director, GlaxoSmithKline Pharmaceuticals, India. 'We fully support the government in its efforts to increase access to affordable medicines to improve healthcare and we are very excited to begin work on what will become our largest manufacturing facility in India.
'With this new facility, we aim to further strengthen our commitment to helping the patients in India to improve their health and well-being.’